How Did I Get Scabies Again

Diseases. 2019 Mar; 7(1): 3.

Infected with Scabies Over again? Focus in Direction in Long-Term Care Facilities

Chong Yau Ong

^oneDepartment of Family Medicine, Division of Medicine, Sengkang General Infirmary, Singapore 544886, Singapore; gs.moc.htlaehgnis@alawnasav.nidurhkaf.dahraf

²SingHealth Knuckles-NUS Family Medicine Academic Clinical Programme, Singapore 544886, Singapore

Farhad Fakhrudin Vasanwala

¹Department of Family Medicine, Segmentation of Medicine, Sengkang General Infirmary, Singapore 544886, Singapore; gs.moc.htlaehgnis@alawnasav.nidurhkaf.dahraf

²SingHealth Duke-NUS Family Medicine Academic Clinical Programme, Singapore 544886, Singapore

Received 2018 Nov 28; Accepted 2018 December 22.

Abstruse

Scabies is a significant public health condition in long-term care facilities, plaguing even developed countries. Although treatments are bachelor, eradication and control of scabies cases all the same remain a challenge due to delays in diagnosis and difficulties in maintaining preventive and surveillance measures. Prompt treatment of patients and their contacts that are affected, along with concomitant education of wellness staff and family members, are paramount. Ecology disinfestation is too a business.

Keywords: scabies, mites, long-term intendance

1. Introduction

Scabies is often a neglected parasitic disease. Information technology has long been known to human beings, commencement described by the renowned physician Jeremy Thriverius of the Habsburgian Low Countries during the 16th century. The causal relationship between skin infestation and the scabies mite was showtime established by Giovan Cosimo Bonomo, an Italian physician, and the apothecary Diacinto Cestoni [1]. Scabies is a pregnant public wellness condition both in resource-poor and developed countries [2], affecting individuals of every age and socioeconomic status [3]. Incidentally, the role of poor hygiene in scabies occurrence has been overestimated and is probably more attributable to overcrowding [4,5,half-dozen]; this is noted in institutional outbreaks, where loftier standards of cleanliness are observed [7,8]. Outbreaks in residential and long-term care facilities, nonetheless, are usually caused by diagnosis delay and are therefore difficult to control [9].

i.1. Epidemiology

A systematic review of population-based studies found the highest prevalence of scabies in Papua New Guinea, Panama, and Fiji [10,11]. Scabies caused 0.21% of Disability-Adjusted Life Years (DALYs) from all conditions studied by the Global Burden of Disease (GBD) 2015 [11]. A review of institutional scabies outbreaks globally revealed that 48% of the outbreaks occurred in residential care facilities for the elderly [12,13]. Prevalence of institutional scabies is probably underestimated [fourteen].

In one review of 206 outbreaks in elderly intendance facilities caused past 37 pathogens, scabies was the 5th about reported pathogen after influenza and noroviruses, Salmonella spp., and Group A Streptococcus [15]. Scabies has loftier median assault rates for health care workers at 36%, only slightly less than Chlamydia pneumonia (41%) and noroviruses (42%) [xv].

1.two. Transmission

This ectoparasite infestation is acquired by the mite Sarcoptes scabiei multifariousness hominis. Southward. scabiei is a fellow member of the family unit Sarcoptidae, within the grade Arachnida. Both male and female mites are invisible to the unaided eye; the maximum adult size is 0.45 mm [4,xvi].

Scabies is transmitted through peel-to-skin contact, though less frequently through fomites (inanimate objects capable of transmitting an infectious organism such as wearable, towels, and bed linens) [17,18,19,20]. Among adults, sexual contact is an established fashion of transmission [iii].

Mites dislodged from an infested individual utilize odor and heat to locate a new host [4]. The probability of being infected is related to the number of mites on the infested individual and the length of contact [3,17].

Away from the host, mites are able to survive and stay capable of infestation for 24–36 h at 21 °C with 40–80% relative humidity [21]. In colder temperatures and college humidity, they can survive even longer. The mites have been reported to be capable of survival for 19 days at x °C and 97% relative humidity, although they are unable to move and penetrate pare at temperatures beneath 20 °C [4,21]. Scabies mites survive less than 24 h in a temperature of 34 °C [2]. To a lesser extent, manual can happen through fomites [18,xix,21,22,23].

1.iii. Parasite Lifecycle and Incubation Period

Female mites burrow into the epidermis, while male mites explore the skin for an unfertilized female. Female mites live for 4–6 weeks, producing 2–4 ova a mean solar day [xvi,24]. A single female person mite can produce upward to 40 ova during her lifetime, the larvae hatching 2-4 days thereafter. Larvae molt into protonymphs (three–4 days) and then tritonymphs (2–5 days) before turning into developed male or female person mites (5–vi days). In total, mature adults develop within 10 to xiv days [2].

The incubation period for naïve patients without previous exposure to scabies is two–6 weeks. However, this period is shorter in people who have been previously infested, whereby symptoms typically develop within ane to 5 days of re-exposure due to rapid sensitization [iii,18].

2. Clinical Presentation

The two major clinical variants of scabies are classic and crusted. Classic scabies, the most common presentation, is associated with a relatively low mite burden (approximately 10–15 mites on the body). Crusted scabies usually occurs in older adults, individuals with dementia, immunocompromised individuals, and individuals with severe neurological disease [9,25,26]. It is associated with a higher mite brunt of upward to millions of mites on the body [27]. Other forms of scabies include bullous scabies that can mimic bullous pemphigoid, scabies incognito, and hidden scabies [28].

2.1. Distribution of Rash

The pathognomonic signs of scabies are burrows, erythematous papules, along with the symptom of pruritus (nocturnal predominance) [2,four]. Burrows are serpiginous, whitish lines in the upper epidermis, measuring several millimeters in length. Typical areas where signs of infestation can be observed are the interdigital spaces of the hand, flexural aspect of the wrists, elbows, penis shaft, nipples, buttocks, axillae, and periumbilical surface area.

In infants and the elderly, classic scabies can present atypically on the head, face, back, and diaper surface area [two,24,29]. Crusted (or Norwegian) scabies impact patients with HIV-infection, human T-cell lymphotropic virus type 1, other immunocompromised patients, and those with sensory and motor neuropathy or dementia [29,30,31,32]. Sometimes it affects persons without apparent risk factors [3]. Lesions are described equally erythematous, hyperkeratotic, psoriasiform, warty, and exfoliating, scaly rash over the scalp, face up, fingers, genitalia, and even nails [four,29]. Inappropriate long-term application of potent topical steroids, especially in the elderly, tin lead to crusted scabies [29].

2.two. Host Immune Response

Delayed type Four hypersensitivity, established as a machinery leading to signs and symptoms of scabies, occurs as a reaction against the scabies mite's saliva, eggs, or feces (sycbala) [18]. The reaction tin can be delayed for upwardly to four weeks, which accounts for long latency of the disease [33].

Both cell-mediated host immune response and humoral response play roles in the host immune response [2,18]. Increased serum levels of IgG and IgE (combined with peripheral eosinophilia) are not protective against reinfestation [two].

2.3. Complications

Scabies mites are not known to transmit secondary infections. However, severe scratching can lead to secondary skin infection. Secondary peel infections are not limited to boils, cellulitis, pyoderma, or lymphangitis due to Streptococcal pyogenes. Streptococci and staphylococci take been isolated from pare burrows as well as mite fecal pellets, suggesting that the mites themselves may contribute to the spread of pathogenic leaner [five]. Bacterial superinfections, however, are uncommon in immunocompetent adults living in Western countries [34]. Secondary infection of scabies with S. pyogenes is a major precipitant of acute mail service streptococcal glomerulonephritis and possibly rheumatic fever [4,35].

3. Diagnosis

Diagnosis is based on the contact history of the patients, health intendance workers, or even family members. The combination of pruritic eruptions, characteristic lesions and their distribution, and the identification of mites, eggs, or feces on pare scrapings confirm the diagnosis.

In practise, burrows are oftentimes obliterated by bathing, scratching, germination of crusts, or superinfection [4]. Visibility of burrows tin be improved with an ink burrow test, where burrows will absorb the ink and exist readily apparent as ink-filled wavy lines where the mite has tunneled, called the stratum corneum [36].

The usual method of obtaining skin samples is accomplished through skin scraping. In this method, the scalpel should ideally be oil-covered as the oil helps to continue the scraped content adhering to the blade [ii]. Multiple superficial skin samples should be obtained from characteristic lesions by scraping laterally across the skin cautiously to avert bleeding [24]. Scrapings are so placed on a covered slide for straight microscopic examination.

Video dermatoscopy is suitable for clinching diagnosis in children. With a magnification of up to 600 times, mites and burrows tin be identified [37]. Use of a handheld dermatoscope requires training to recognize the typical "jet with condensation trail" pattern. Performed by a trained practitioner, dermatoscopy yields high accurateness in diagnosing scabies [38,39].

Epiluminescence microscopy using dermatoscopy has as well been used in dermatology clinics to identify in vivo mites with good sensitivity [40]. Incident calorie-free microscopy (with a magnification of up to 200×) and reflectance-mode confocal microscopy have also been found to have high diagnostic sensitivity [41,42]. Serology tests have yet to be successful in man infestations [43]. Complementary Deoxyribonucleic acid libraries have been synthetic for S scabiei var. hominis, but commercial molecular diagnostic tests take non yet been developed [38,44,45].

The International Alliance for the Control of Scabies (IACS) recently released a consensus on diagnosis of scabies with high agreement (Table one) [46].

Tabular array 1

The 2018 International Alliance for the Command of Scabies (IACS) criteria for the diagnosis of scabies.

A: Confirmed scabies
At least one of:
A1: Mites, eggs, or feces on light microscopy of peel samples
A2: Mites, eggs, or feces visualized on private using high-powered imaging device
A3: Mite visualized on individual using dermoscopy

B: Clinical scabies
At least one of:
B1: Scabies burrows
B2: Typical lesions affecting male genitalia
B3: Typical lesions in a typical distribution and two history features

C: Suspected scabies
One of:
C1: Typical lesions in a typical distribution and ane history feature
C2: Atypical lesions or singular distribution and two history features

History features
H1: Itch
H2: Close contact with an individual who has itch or typical lesions in a typical distribution

Notes:
i. These criteria should be used in conjunction with the total explanatory notes and definitions (in preparation).
2. Diagnosis can exist fabricated at one of the 3 levels (A, B, or C).
3. A diagnosis of clinical and suspected scabies should only be fabricated if other differential diagnoses are considered less probable than scabies.

Identification and early treatment of suspected scabies is disquisitional especially in residential or care facilities. Delays in diagnosis accept been reported in nursing homes where it was misdiagnosed as eczema and other skin conditions by visiting general practitioners (GPs) until that diagnosis was superseded by another GP [25]. Most nursing homes and institutional residential or intendance facilities do not have access to specialist dermatological support [25].

Differential Diagnoses

The list of differential diagnoses is all-encompassing and includes atopic dermatitis, contact dermatitis, folliculitis, impetigo, papular urticarial, bites (from midges, fleas, lice, bedbugs, and other mites), and tinea [2,iii]. Almost all pruritic dermatoses have to be considered differential diagnoses [4].

four. Management

4.1. Principles of Handling

The principle of treatment of scabies is rapid isolation and treatment of the alphabetize instance, identifying contacts, and ecology disinfestations [47]. It is imperative for the shut contacts of individuals diagnosed with scabies to be treated simultaneously because they may have been infected without yet manifesting the symptoms, and so deed as reservoirs for infection [48,49,50,51]. Isolation and locking of doors for residents with dementia and wandering behavior is essential, although it tin can exist deplorable to them and staff [25].

iv.2. Topical and Oral Agents

Virtually scabies infestations are treatable with scabicides. It is essential that steps for environmental disinfection take place simultaneously with medical handling. Topical treatments typically require awarding from the neck down to the soles of the feet (including fingernails and toenails) for elapsing of many hours. At that place is no international consensus on the advisable schedule of treatment, and recommendations in one jurisdiction may not be applicable in others [14,48,52].

In a review of interventions for scabies, permethrin was institute to be more effective than other scabicides [53]. A recent review institute no difference detected in the efficacy of permethrin in comparing to ivermectin [54]. Although malathion has been used with success in many centers, in that location are no trials to compare the effectiveness of malathion confronting other scabicides [53]. Table 2 summarizes commonly used treatments for scabies.

Tabular array 2

Summary of treatments for scabies.

Drug Name and Preparation	Dosage and Instruction	Major Side Effects	Notes or Contraindications
Topical
Permethrin	five% cream. Rinse off after viii–14 h. 2d awarding ane calendar week afterwards the first. Crusted scabies: Apply daily for 7 days, and so 2x/week until cured. Combination therapy with oral ivermectin.	Itch and sting on application.	Not to exist used in infants nether age ii months. Tin can be used in infants and breastfeeding mothers.
Benzyl benzoate	ten–25% balm. Rinse off afterwards 24 h. Alternatively, utilise overnight for 2 consecutive days. Second application 1 week after the first. Crusted scabies: Employ daily for seven days, and then 2x/week until cured. Combination therapy with oral ivermectin.	Burning and sting on awarding.	Non recommended in infants below half dozen months (dilutional doses) required. Disulfiram-like effects if alcohol is consumed less than 48 h prior to application.
Crotamiton	10% cream. Utilise to nodules for 24 h, rinse off, and reapply for another 24 h.	None	Safety in children has not been established.
Precipitated sulfur	3–6% lotion, 5–40% petrolatum. Employ for 24 h and so reapply every 24 h for the next ii days. Alternatively, apply overnight for iii consecutive days.	None	Inexpensive. Used in neonates, pregnant women, and breastfeeding mothers.
Malathion	0.5% lotion. Rinse off afterwards 24 h. Repeat awarding later one calendar week.	Burning and sting on application.
Oral
Ivermectin	3 mg tablets. Single dose of 200 mcg/kg body weight. Second dose ii weeks afterward. Crusted scabies: 200 mcg/kg/dose on days i, two, 8, 9, and fifteen. Combination use with permethrin/or benzyl benzoate. Apply for 7 days, then 2x/calendar week until cure.		Contraindicated in children less than 15 kg or meaning and breastfeeding mothers. Absorption tin can exist improved with fatty meals. Intendance must be taken when administered with drugs that can broaden GABA activeness (valproate, barbiturates, and benzodiazepines).

Antihistamines and emollients are useful for symptomatic management of crawling, including medication-related mail-scabetic itch [49]. Topical keratolytics such every bit salicylic acid can be used to treat crusted scabies. Information technology is practical on days where scabicide is not practical.

4.3. Drug Resistance and Other Treatments

Of tardily, the resistance to scabicides has been increasingly reported [55,56,57,58,59]. Four unlike players that could potentially contribute to scabicide resistance take been identified as follows: (a) voltage-gated sodium channels, (b) glutathione Southward-transferase (GST), (c) ATP-bounden cassette transporters, and (d) ligand-gated chloride channels [57].

Moxidectin (an established treatment of scabies in dogs and sheep) is currently being evaluated as an oral agent for scabies. Information technology is related to ivermectin and has the aforementioned mechanism of activity, only is more lipophilic (retains in tissue longer). The prospect of moxidectin as future therapy for scabies has been promising [60,61,62].

Vaccination has been shown to accept some potential in controlling scabies epidemics [63]. The development of a vaccine against scabies is still being conducted [57,64].

iv.iv. Environmental Disinfestation

Isolation rooms should be cleansed thoroughly. Residential and care facility staff should avoid direct skin-to-skin contact by using protective garments such as gowns and gloves. Correct handling of disposed protective garments should likewise exist observed.

Infested individuals' bedding, wearable, towels, and personal bed jackets should be separately motorcar-laundered using hot h2o to a higher place 75 °C, followed by hot dryer cycles. No special processing such every bit autoclaving or bleaching is required [sixteen]. Items that are unable to exist laundered, such as shoes, should be placed in a plastic bag and left for 72 h [16,19]. Amenities and equipment such every bit geriatric chairs, commodes, and toilets should non exist shared until 24 h post treatment [19]. Chloramine 5% has been used to disinfect rooms of infested individuals [47].

4.5. Management of Complications or Handling Failure

Resolution of agile lesions and alleviation of pruritus signal that therapy has probable been successful. Having said that, pruritus may persist 2 to 4 weeks afterward successful treatment and tin be role of the resolution process or acquired by post-scabetic dermatitis. In this example, scabies scrapes can exist repeated postal service wash-out of topical scabicides to confirm eradication.

Confirmed treatment failure can be largely attributed to ineffective application of topical scabicides and incomplete environmental command [65]. Alternative therapies should exist considered in the example of resistance to initial therapies.

four.6. Management of Outbreak and Prevention Programme

In residential homes and care facilities, early recognition of scabies is essential to prevent outbreaks [50]. Diagnosis may be delayed because of the less familiar manner that scabies tin present in the elderly [66]. Once an outbreak occurs, prompt control of the index patient and rapid tracing of contacts to identify secondary cases are necessary (Figure 1) [48,49]. When prolonged exposure to a case of scabies results in multiple secondary cases, institution of simultaneous mass prophylaxis is the almost efficient strategy for terminating the outbreak and can be implemented without ward closure, although the logistic aspects are considerable [fifty]. However, an aggressive approach of the minimization of transmission pathways such equally the reduction of staff rotation, counterfoil of community activities, and if possible, of new admissions (ward closure), has too been recommended [67].

An external file that holds a picture, illustration, etc. Object name is diseases-07-00003-g001.jpg

Workflow for management of scabies in long term care facilities.

Due to the unavailability of well-designed, randomized controlled trials (RCTs) to provide conclusive show of safety measures, information technology is unclear whether prophylaxis is more advisable than a "wait and run into" approach, whereby contacts are educated regarding the possibility of infection and advised to seek medical consultation should they develop symptoms suggestive of infection [48,49].

In the review of prevention strategies, the authors summarized the concerns and barriers for prophylaxis (Tabular array 3) [48]. In general, control of large outbreaks is distressing and requires meaning effort in terms of time, money, organization, coordination, and teamwork amid healthcare staff [25,68].

Tabular array 3

Concerns and challenges in mass prophylaxis.

i)

Delivery and willingness of exposed contacts to undergo treatment [69].
ii)

Substantiating the degree of contact of exposed individuals with the index example, including those who are unable to consent for handling [seventy].
3)

Side furnishings of therapy [14].
4)

Possibility of drug resistance against anti-scabetic treatments [49,56].
5)

Stigma associated with diagnosis, which may lead to reluctance in disclosure of diagnosis to close contacts [4,12,67].
six)

Cost associated with providing medical treatment to all contacts [12,25,71] and getting medications in bulk [25].
7)

Logistical difficulties in identifying all contacts of an index case [12,25,69].

Long-term care facilities should possess a scabies prevention program. Such a program should include assessment of peel, hair, and nails for all new admissions equally they go far [72]. Any lesions suspected to be scabies and other dermatological conditions should be escalated to the doctor. Fourth dimension should be allocated to deport this cess periodically. Nonetheless, in practice, long-term care facilities often suffer inadequate staffing.

Prolonged surveillance in the eradication of scabies in long-term intendance facilities is needed due to the dynamics of residents and rotation of staff [73]. New cases can occur due to the transfer of new residents with unrecognized scabies, as well as existing residents who returned to the facilities subsequently contracting scabies from another infirmary.

4.vii. Contact Tracing

Concurrent treatment of contacts and individuals diagnosed with scabies is important, as the onset of symptoms is often delayed and therefore contacts may have active scabies while they are asymptomatic of pruritus. Family members that co-addiction, including domestic workers, as well as family members and visitors of the diagnosed individuals upwards to half-dozen weeks prior to the diagnosis should be identified and treated.

In residential and care facilities, all persons that are in contact with the afflicted individuals should be traced and treated. This includes doctors, nurses, social workers, volunteers, therapists, administration, porters, security officers, and visitors. This can be done through the checking of electronic systems used for keeping rail of staff and visitors who enter the affected ward or cubicle. Registration of staff or visitors using books should be washed and subsequently traced during an outbreak if the entrances to the wards are not digitally captured. This tin can be logistically challenging in nursing homes and care facilities with day care services, including short and long term patients [47]. Identified contacts should exist treated with the aforementioned regimen used for classic scabies. Cooperation and compliance of health intendance workers and visitors is needed for successful treatment [74].

Restriction of staff rotation in the intendance facility has been identified as ane of the steps of the successful control of outbreaks [73]. Nurses who are caring for symptomatic patients and residents in the same ward are required to examine themselves regularly, and if found to exist symptomatic, are instructed to contact the ward employee in charge in social club to exist excused from piece of work [75]. Infested staff tin render to work 24 h afterward their first scabicide treatment [xix].

In resource-acceptable settings, we suggest a multi-disciplinary team consisting of a minimum of half-dozen members to address the treatment and preventive aspects of scabies infestation (Figure 2). Meetings should exist conducted to update the progress of the treatment of cases and their contacts and identification of new cases [67]. In resource-express settings, public health nurses or trained individuals tin exist tasked to chair, coordinating the preventive measures.

An external file that holds a picture, illustration, etc. Object name is diseases-07-00003-g002.jpg

Multi-disciplinary (MDT) Team. Dr. A: Chair the give-and-take and oversee the control steps. Reports to higher management on the care plans. Nurse A: Oversees the screening of nurses and prophylactic treatments. Ensures the nurses adhere to contact precautions and hand hygiene. Supervises the cleaning of fomites and surround. Case Director: Trace all contacts of the diagnosed private through digital or newspaper records. Contact them and refer them for treatment. Md B and Nurse B: Treat and reassess all cases of scabies. Provide treatment for contacts. Centrolineal Wellness Representative: Ensure the allied health and other health intendance workers adhere to contact precautions and hand hygiene. Assist Case Manager in contact tracing.

5. Recommendations

Information technology is imperative that early identification of the alphabetize example and subsequent contact tracing exist performed during the onset of an outbreak; followed by treatment are the principles of management. Loftier adherence to contact precautions and fomite cleaning are of import steps that are often ignored.

Finally, continuous, vigilant surveillance of scabies in residential and long-term care facilities and activation of dedicated MDT teams to address the outbreak is the cornerstone of curbing scabies infestation in a long-term intendance institution.

Author Contributions

All authors are involved with conceptualization, writing, and approval the manuscript.

Funding

This inquiry received no external funding.

Conflicts of Involvement

The authors declare no conflict of interest.

References

ane. Ramos-e-Silva M. Giovan Cosimo Bonomo (1663–1696): Discoverer of the etiology of scabies. Int. J. Derm. 1998;37:625–630. doi: 10.1046/j.1365-4362.1998.00400_1.x. [PubMed] [CrossRef] [Google Scholar]

2. Hengge U.R., Currie B.J., Jäger Grand., Lupi O., Schwartz R.A. Scabies: A ubiquitous neglected skin disease. Lancet Infect. Dis. 2006;vi:769–779. doi: 10.1016/S1473-3099(06)70654-5. [PubMed] [CrossRef] [Google Scholar]

3. Walton S.F., Currie B.J. Problems in diagnosing scabies, a global illness in human and animal Populations. Clin. Microbiol. Rev. 2007;20:268–279. doi: ten.1128/CMR.00042-06. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

4. Heukelbach J., Feldmeier H. Scabies. Lancet. 2006;367:1767–1774. doi: ten.1016/S0140-6736(06)68772-2. [PubMed] [CrossRef] [Google Scholar]

5. Currie B.J., Connors C.M., Krause 5.L. Scabies programs in aboriginal communities. Med. J. Aust. 1994;161:636. [PubMed] [Google Scholar]

6. Heukelbach J., Wilcke T., Winter B., Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resources-poor communities in Brazil. Br. J. Derm. 2005;153:150–156. doi: 10.1111/j.1365-2133.2005.06591.x. [PubMed] [CrossRef] [Google Scholar]

seven. Holness D.L., DeKoven J.G., Nethercott J.R. Scabies in chronic wellness care institutions. Curvation. Dermatol. 1992;128:1257–1260. doi: x.1001/archderm.1992.01680190113015. [PubMed] [CrossRef] [Google Scholar]

8. Parish L.C., Witkowski J.A., Mililikan L.Eastward. Scabies in extended intendance facility. Int. J. Dermatol. 1991;xxx:703–706. doi: ten.1111/j.1365-4362.1991.tb02613.x. [PubMed] [CrossRef] [Google Scholar]

ix. Cassell J.A., Middleton J., Nalabanda A., Lanza South., Caput M.G., Bostock J. Scabies outbreaks in ten care homes for elderly people: A prospective report of clinical features, epidemiology, and treatment outcomes. Lancet Infect. Dis. 2018;18:894–902. doi: 10.1016/S1473-3099(eighteen)30347-5. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

10. Romani L., Whitefield Thou.J., Koroivueta J., Kama K., Wand H., Tikoduadua L. Mass Drug Administration for Scabies Control in a Population with Endemic Disease. N. Engl. J. Med. 2015;37:2305–2313. doi: 10.1056/NEJMoa1500987. [PubMed] [CrossRef] [Google Scholar]

11. Karimkhani C., Colombara D.V., Drucker A.Yard., Norton S.A., Hay R., Engelman D. Article The global brunt of scabies: A cantankerous-exclusive analysis from the Global Burden of Disease Written report 2015. Lancet Infect. 2015;17:1247–1254. doi: 10.1016/S1473-3099(17)30483-8. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]

12. Mounsey Yard.E., Murray H.C., King M., Oprescu F. Retrospective assay of institutional scabies outbreak from 1984 to 2013: Lessons learned and moving forward. Epidemiol. Infect. 2016;144:2462–2471. doi: x.1017/S0950268816000443. [PubMed] [CrossRef] [Google Scholar]

13. White L.C.J., Lanza Due south., Middleton J., Hewitt Yard. The management of scabies outbreaks in residential care facilities for the elderly in England: A review of current health protection guidelines. Epidemiol. Infect. 2016;144:3121–3130. doi: 10.1017/S0950268816001746. [PubMed] [CrossRef] [Google Scholar]

14. Bouvresse Southward., Chosidow O. Scabies in healthcare settings. Curr. Opin. Infect. Dis. 2010;23:111–118. doi: 10.1097/QCO.0b013e328336821b. [PubMed] [CrossRef] [Google Scholar]

15. Utsumi 1000., Makimoto K., Quroshi Due north., Ashida N. Types of infectious outbreaks and their impact in elderly intendance facilities: A review of the literature. Historic period Ageing. 2010;3:299–305. doi: ten.1093/ageing/afq029. [PubMed] [CrossRef] [Google Scholar]

16. Currie B.J., McCarthy J.Due south. Permethrin and Ivermectin for Scabies. North. Engl. J. Med. 2010;362:717–725. doi: x.1056/NEJMct0910329. [PubMed] [CrossRef] [Google Scholar]

xviii. Mellanby Chiliad. The development of symptoms, parasitic infection and immunity in homo scabies. Parasitology. 1944;35:197–206. doi: ten.1017/S0031182000021612. [CrossRef] [Google Scholar]

19. Wellness Protection Programs and the Communicable Disease Control Co-operative. Department of Health and Ageing SA . Scabies Management in Intendance Facilities, 2012: Direction Guidelines for the Control of Scabies in Wellness and Residential Intendance Facilities. Department for Wellness and Ageing, Government of South Australia; Adelaide, Commonwealth of australia: 2012. [Google Scholar]

20. Green Grand. Epidemiology of scabies. Epidemiol. Rev. 1989;11:126–150. doi: x.1093/oxfordjournals.epirev.a036033. [PubMed] [CrossRef] [Google Scholar]

21. Arlian L.G., Morgan M.South. A review of Sarcoptes scabiei: Past, present and time to come. Parasit. Vectors. 2017;10:297. doi: 10.1186/s13071-017-2234-1. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]

22. Haag Grand., Brozena S., Fenske N.A. Attack of the scabies: What to do when an outbreak occurs. Geriatrics. 1993;48:45–46. [PubMed] [Google Scholar]

23. Sterling Yard., Jamiger C., Kihiczak G., Schwartz R., Fox Grand. Scabies. Am. Fam. Physician. 1992;46:1237–1241. [PubMed] [Google Scholar]

24. Chosidow O. Scabies. N. Engl. J. Med. 2006;354:1718–1727. doi: 10.1056/NEJMcp052784. [PubMed] [CrossRef] [Google Scholar]

25. Hewitt K., England P.H., Nalabanda A., Cassell J. Scabies outbreaks in residential intendance homes: Factors associated with late recognition, burden and touch. A mixed methods study in England Scabies outbreaks in residential intendance homes: Factors associated with late recognition, brunt and impact. A mixed methods study in England. Epidemiol. Infect. 2015;143:1542–1551. doi: ten.1017/S0950268814002143. [PubMed] [CrossRef] [Google Scholar]

26. Tsutsumi Chiliad., Nishiura H., Kobayashi T. Dementia-specific risks of scabies: Retrospective epidemiologic analysis of an unveiled nosocomial outbreak in Nihon from 1989–ninety. BMC Infect. 2005;5:85. doi: 10.1186/1471-2334-v-85. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]

27. Currie B.J., Huffam S., O'Brien D., Walton Southward. Ivermectin for scabies. Lancet. 1997;350:1551. doi: 10.1016/S0140-6736(05)63983-9. [PubMed] [CrossRef] [Google Scholar]

28. Cestari T.F., Martignago B.F. Scabies, pediculosis, bedbugs, and stinkbugs: Uncommon presentations. Clin. Derm. 2005;23:545–554. doi: 10.1016/j.clindermatol.2005.01.013. [PubMed] [CrossRef] [Google Scholar]

29. Chosidow O. Scabies and pediculosis. Lancet. 2000;355:819–826. doi: 10.1016/S0140-6736(99)09458-1. [PubMed] [CrossRef] [Google Scholar]

30. Elosua-González K., García-Zamora E. Crusted scabies. Due north. Eng. J. Med. 2017;377:476. doi: 10.1056/NEJMicm1616169. [PubMed] [CrossRef] [Google Scholar]

31. Lanza Southward., Middleton J., Caput 1000.G., Bostock J., Nalabanda A., Walker S.50. Can outbreak research be accomplished in a population with impaired chapters? Findings from a study of a scabies outbreak in residential care. Lancet. 2015;386:S48. doi: 10.1016/S0140-6736(15)00886-7. [CrossRef] [Google Scholar]

32. Sirera G., Romeu J., Ribera M., Tor J., Rius F., Llibre J.Chiliad., Soriano Five., Ferrandiz C., Clotet B. Hospital outbreak of scabies stemming from ii AIDS patients with Norwegian scabies. Lancet. 1990;335:1227. doi: x.1016/0140-6736(90)92754-vi. [PubMed] [CrossRef] [Google Scholar]

33. Estes S.A., Estes J. Scabies research: Another dimension. Semin. Dermatol. 1993;12:34–38. [PubMed] [Google Scholar]

34. Esposito 50., Veraldi S. Skin bactrerial colonizations and superinfections in immunocompetent patients with scabies. Int. J. Dermatol. 2018;57:1218–1220. doi: 10.1111/ijd.14123. [PubMed] [CrossRef] [Google Scholar]

35. Hersch C. Astute glomerulonephritis due to pare affliction, with special reference to scabies. South. Afr. Med. J. 1967;41:29–34. [PubMed] [Google Scholar]

36. Woodley D., Saurat J.H. The burrow ink examination and the scabies mite. J. Am. Acad. Dermatol. 1981;4:715–722. doi: ten.1016/S0190-9622(81)80204-6. [PubMed] [CrossRef] [Google Scholar]

37. Micali G., Lacarrubba F.L.G.Yard. Scraping versus videodermatoscopy for the diagnosis of scabies: A comparative study. Acta Dermatol. Venereol. 1999;79:396. [PubMed] [Google Scholar]

38. Leung 5., Miller M. Detection of scbies: A systematic review of diagnostic methods. Tin can. J. Infect. Dis. Med. Microbiol. 2011;22:143–146. doi: 10.1155/2011/698494. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]

39. Dupuy A., Dehen L., Bourrat E., Lacroix C., Benderdouche M., Dubertret L. Accurateness of standard dermoscopy for diagnosing scabies. J. Am. Acad. Dermatol. 2007;56:53–62. doi: ten.1016/j.jaad.2006.07.025. [PubMed] [CrossRef] [Google Scholar]

40. Argenziano G., Fabbrocini M., Delfino Thou. Epiluminescence microscopy. A new approach to in vivo detection of Sarcoptes scabies. Arch. Dermatol. 1997;133:751–753. doi: x.1001/archderm.1997.03890420091011. [PubMed] [CrossRef] [Google Scholar]

41. Brunetti B., Vitiello A., Delfino S., Sammarcco Due east. Findings of in vivo of Sarcoptes scabiei with inident calorie-free microscopy. Eur. J. Dermatol. 1998;8:266–267. [PubMed] [Google Scholar]

42. Bauer J., Blum A., Sonnichsen One thousand., Metzler G., Rassner Chiliad., Garbe C. Nodular scabies detected past computed dermatoscopy. Dermatology. 2001;203:190–191. doi: 10.1159/000051742. [PubMed] [CrossRef] [Google Scholar]

43. Kuhn C., Lucius R., Matthes H.F., Meuseul G., Reich B., Kalinna B.H. Characterisation of recombinant immunreactive antigens of the scab mite Sarcoptes scabiei. Vet. Parasitol. 2008;153:329–337. doi: ten.1016/j.vetpar.2008.02.007. [PubMed] [CrossRef] [Google Scholar]

44. Casais R., Prieto Thousand., Balseiro A., Solano P., Parra F., Martin Alonso J.M. Identification and heterologous expression of a Sarcoptes scabiei cDNA encoding a structural antigen with immunodiagnostic potential. Vet. Res. 2007;38:435–450. doi: ten.1051/vetres:2007007. [PubMed] [CrossRef] [Google Scholar]

45. Alasaaad S., Rossi Fifty., Soriguer R.C., Rambozzi Fifty., Soglia D., Perez J.M. Sarcoptes mite from collection to DNA extraction: The lost realm of the neglected parasite. Parasitol. Res. 2009;104:723–732. doi: 10.1007/s00436-009-1333-0. [PubMed] [CrossRef] [Google Scholar]

46. Engelman D., Fuller Fifty.C., Steer A.C. Consensus criteria for the diagnosis of scabies: A Delphi report of international experts. PLoS Negl. Trop. Dis. 2018;12:e0006549. doi: 10.1371/periodical.pntd.0006549. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]

47. Andersen B.M., Haugen H., Rasch M., Haugen A.H., Tageson A. Outbreak of scabies in Norwegian nursing homes and home care patients: Command and prevention. J. Hosp. Infect. 2000:160–164. doi: ten.1053/jhin.1999.0716. [PubMed] [CrossRef] [Google Scholar]

48. Fitzgerald D., Grainger R.J., Reid A. Interventions for preventing the spread of infestation in shut contacts of people with scabies (Review) Cochrane Database Syst. Rev. 2014 doi: x.1002/14651858.CD009943.pub2. [PubMed] [CrossRef] [Google Scholar]

49. Chouela E., Abeldano A., Pellerano G., Hernandez M.I. Diagnosis and treatment of scabies. Am. J. Clin. Dermatol. 2002;3:ix–eighteen. doi: 10.2165/00128071-200203010-00002. [PubMed] [CrossRef] [Google Scholar]

fifty. Schienfield N. Controlling scabies in institutional settings: A review of medication, treatment models, and implementation. Am. J. Clin. Dermatol. 2004;5:31–37. doi: 10.2165/00128071-200405010-00005. [PubMed] [CrossRef] [Google Scholar]

51. Strong Thousand., Johnstone P. Interventions for treating scabies (Review) Cochrane Database Syst. Rev. 2010;3:CD000320. [PMC free article] [PubMed] [Google Scholar]

52. Paasch U., Haustein U.F. Management of owned outbreaks of scabies with allethrin, permethrin, and ivermectin. Int. J. Dermatol. 2000;39:463–470. doi: 10.1046/j.1365-4362.2000.00990.x. [PubMed] [CrossRef] [Google Scholar]

53. Ladbury G., Morroy Yard., van Hoeven-Dekkers South., Bottermans C., Veelenturf C., Bastiaens M. An outbreak of scabies in multiple limked healthcare settings in kingdom of the netherlands. Infect. Command. Hosp. Epidemiol. 2012;33:1047–1050. doi: x.1086/667736. [PubMed] [CrossRef] [Google Scholar]

54. Stiff M., Johnstone P. Cochrane review: Interventions for treating scabies. Evid.-Based Child. Health A Cochrane Rev. J. 2011;half dozen:1790–1862. doi: 10.1002/ebch.861. [CrossRef] [Google Scholar]

55. Mounsey K.E., Holt D.C., McCarthy J.S., Currie B.J., Walton Southward.F. Longitudinal show of increasing in vitro tolerance of scabies mites to ivermectin in scabies-endemic communities. Arch. Dermatol. 2009;145:840–841. doi: ten.1001/archdermatol.2009.125. [PubMed] [CrossRef] [Google Scholar]

56. Currie B.J., Harumal P., McKinnon M., Walton S.F. Beginning documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin. Infect. Dis. 2004;39:e8–e12. doi: x.1086/421776. [PubMed] [CrossRef] [Google Scholar]

57. Khalil S., Abbas O., Kibbi A.1000., Kurban Thousand. Scabies in the age of increasing drug resistance. PLoS Negl. Trop. Dis. 2017;11:e0005920. doi: ten.1371/journal.pntd.0005920. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]

58. Thomas J., Peterson G.Grand., Walton S.F., Carson C.F., Naunton One thousand., Baby K.E. Scabies: An ancient global disease with a need for new therapies. BMC Infect Dis. 2015;15:250. doi: 10.1186/s12879-015-0983-z. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]

59. Roth W. Scabies resistant to lindane i% lotion and crotamiton 10% cream. J. Am. Acad. Dermatol. 1991;24:502–503. doi: 10.1016/S0190-9622(08)80078-three. [PubMed] [CrossRef] [Google Scholar]

60. Mounsey Thou.E., Walton Due south.F., Innes A., Cash-deans SMcCarthy J.S. In Vitro Efficacy of Moxidectin versus Ivermectin confronting Sarcoptes scabiei. Antimicrob. Agents Chemother. 2017;61:i–v. doi: 10.1128/AAC.00381-17. [PMC costless commodity] [PubMed] [CrossRef] [Google Scholar]

61. Mounsey M.East., Bernigaud C., Chosidow O., Mccarthy J.South. Prospects for Moxidectin as a New Oral Treatment for Human being Scabies. PLoS Negl. Trop. Dis. 2016:e0004389. doi: 10.1371/journal.pntd.0004389. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

62. Bernigaud C., Fang F., Fischer Thou., Lespine A., Aho S., Dreau D. Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Ii-Dose Ivermectin in a Porcine Model. PLoS Negl. Trop. Dis. 2016;10:e0005030. doi: 10.1371/periodical.pntd.0005030. [PMC costless article] [PubMed] [CrossRef] [Google Scholar]

63. Bhunu C.P., Mushayabasa S., Monera T.Thousand. Assessing the Touch of Vaccination on Controlling the Spread of Man Scabies. ISRN Comput. Bio. 2013;2013:362973. doi: 10.1155/2013/362973. [CrossRef] [Google Scholar]

64. Liu X., Walton S., Mounsey K. Vaccine against scabies: Necessity and possibility. Parasitology. 2014;141:725–732. doi: 10.1017/S0031182013002047. [PubMed] [CrossRef] [Google Scholar]

65. Karthikeyan K. Treatment of scabies: Newer perspectives. Postgrad. Med. J. 2005;81:7–11. doi: x.1136/pgmj.2003.018390. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]

66. Wilson Thousand.K., Philpott C.D., Breer W.A. Atypical Presentation of Scabies Among Nursing Habitation Residents. J. Gerentol. Ser. A Biol. Sci. Med. Sci. 2001;56:424–427. doi: 10.1093/gerona/56.7.M424. [PubMed] [CrossRef] [Google Scholar]

67. Stoevesandt J., Carle L., Leverkus K., Hamm H. Command of large istitutional settings: A review of medication, treatment models, and implementation. J. Dtsch. Dermatol. Ges. 2012;10:637–647. doi: x.1111/j.1610-0387.2012.07892.ten. [PubMed] [CrossRef] [Google Scholar]

68. Sunderkötter C., Feldmeier H., Fölster-Holst R., Geisel B., Klinke-Rehbein S., Nast A. S1 guidelines on the diagnosis and treatment of scabies–short version. JDDG. 2016;14:1155–1167. doi: 10.1111/ddg.13130. [PubMed] [CrossRef] [Google Scholar]

69. Buehlmann G., Beltraminelli H., Strub C., Bircher A., Hashemite kingdom of jordan X., Battegay Chiliad. Scabies outbreak in an intensive care unit with 1,659 exposed individuals- key factors for controlling the outbreak. Infect. Command. Hosp. Epidemiol. 2009;30:354–360. doi: x.1086/596113. [PubMed] [CrossRef] [Google Scholar]

70. Ejidokun O.O., Aruna O.S., O'Neill B. A scabies outbreak in a further pedagogy college in Glouchestershire. Epidemiol. Infect. 2007;135:455–457. doi: 10.1017/S0950268806007072. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

71. Vorou R., Remoudaki H.D., Maltezou H.C. Nosocomial scabies. J. Hosp. Infect. 2007;65:9–14. doi: 10.1016/j.jhin.2006.08.012. [PubMed] [CrossRef] [Google Scholar]

72. California Section of Public Health . Prevention and Command Long-Term Care Facilities. California Section of Public Health; Sacramento, CA, USA: 2008. [Google Scholar]

73. Jimenez-Lucho V.E., Fallon F., Caputo C., Ramsey 1000. Function of prolonged surveillance in the eradication of nosocomial scabies in an extended care Veterans Affairs medical center. Am. J. Infect. Control. 1995;23:44–49. doi: 10.1016/0196-6553(95)90008-10. [PubMed] [CrossRef] [Google Scholar]

74. Yonkosky D., Ladia L., Gackenheimer Fifty., Schultz M.Westward., Marlborough M.P.H. Scabies in nursing homes: An eradication program with permethrin 5 % foam. J. Am. Acad. Dermatol. 1990;23:1133–1136. doi: 10.1016/0190-9622(90)70346-J. [PubMed] [CrossRef] [Google Scholar]

75. Khan A., O' Grady South., Muller Chiliad.P. Rapid control of a scabies outbreak at a tertiary care hospital without ward closure. Am. J. Infect. Command. 2012;40:451–455. doi: ten.1016/j.ajic.2011.05.014. [PubMed] [CrossRef] [Google Scholar]

Articles from Diseases are provided here courtesy of Multidisciplinary Digital Publishing Found (MDPI)

gellertgonstornes.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473425/